Thalys Medical Technology Group Corporation

¥15.06As of Sun 8 Nov 2026, 12:00 UTC
SSE:603716Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 3.19%
Div yield —
ROE (17.62%)
Diagnostics & Research
Beta (5Y) 0.35
PE TTM —
TSR TTM (39.76%)
Mkt cap ¥3.341B
ROIC (6.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
4.10%
(73.44%)
Hold 8|9|12|9|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.15
0.15
0.16
11.03%
8.04%
8.73%
14.85%
Revenue¥M
146.5
145.7
152.1
151.6
0.98%
3.39%
7.02%
4.88%
Peers (US$500.8M)
Cap (US$)
PE
540.0M
53.92x
Capital
TTM
5Y
10Y
Leveragex
1.119
(0.012)
(0.012)
EBIT/Intx
0.704
0.110
0.095
Own earn%
14.92
123.49
112.04
Sh yield%
31.51
54.51
53.79
Owners
Insiders/Inst%
3.28
35.07
Short interest%
4.47
SBC / revenue%
2.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
16–21
$1 testx
—
Incr. ROIC%
21